{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:48:06Z","timestamp":1791254886448,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.atherosclerosis.2015.05.018","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T16:03:38Z","timestamp":1433520218000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice"],"prefix":"10.1016","volume":"241","author":[{"given":"Thomas L.","family":"Theelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari P.","family":"Lappalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Sluimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Gurzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack P.","family":"Cleutjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion J.","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.L.","family":"Biessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat J.A.P.","family":"Daemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Alitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib1","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-11-2175","article-title":"Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.05.018_bib2","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1172\/JCI66549","article-title":"Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis","volume":"123","author":"Ziegler","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2261-11-31","article-title":"Circulating angiopoietins-1 and -2, angiopoietin receptor tie-2 and vascular endothelial growth factor-a as biomarkers of acute myocardial infarction: a prospective nested case-control study","volume":"11","author":"Iribarren","year":"2011","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/cvr\/cvp253","article-title":"Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors","volume":"85","author":"Le Dall","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000112939","article-title":"Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density","volume":"45","author":"Post","year":"2008","journal-title":"J.\u00a0Vasc. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/CIRCRESAHA.109.196154","article-title":"Angiopoietin-2 confers atheroprotection in apoe-\/- mice by inhibiting ldl oxidation via nitric oxide","volume":"104","author":"Ahmed","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study","volume":"104","author":"Bowles","year":"2012","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib8","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","article-title":"Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"60","author":"Chen","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1200\/JCO.2010.31.9129","article-title":"Congestive heart failure risk in patients with breast cancer treated with bevacizumab","volume":"29","author":"Choueiri","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab","volume":"99","author":"Scappaticci","year":"2007","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","article-title":"Vegf and angiopoietin signaling in tumor angiogenesis and metastasis","volume":"17","author":"Saharinen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib12","first-page":"1321","article-title":"Medi3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models","volume":"40","author":"Leow","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to tnf-alpha and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib14","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays vegf-dependent modulation of capillary structure and endothelial cell survival in\u00a0vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib15","doi-asserted-by":"crossref","first-page":"e70459","DOI":"10.1371\/journal.pone.0070459","article-title":"Angiopoietin-2 is critical for cytokine-induced vascular leakage","volume":"8","author":"Benest","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/nm1494","article-title":"Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death","volume":"12","author":"Bhandari","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib17","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.4049\/jimmunol.178.11.7405","article-title":"Expression of tie-2 by human monocytes and their responses to angiopoietin-2","volume":"178","author":"Murdoch","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib18","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1093\/eurheartj\/eht301","article-title":"Stabilization of atherosclerotic plaques: an update","volume":"34","author":"Yla-Herttuala","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib19","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.0000143233.87854.23","article-title":"Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability","volume":"110","author":"Moreno","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib20","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2008.12.056","article-title":"Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage","volume":"53","author":"Sluimer","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.103.8.1164","article-title":"Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein e-deficient and low-density lipoprotein receptor-deficient mice","volume":"103","author":"von der Thusen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jnci\/djs009","article-title":"Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis","volume":"104","author":"Holopainen","year":"2012","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib23","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/mt.2012.145","article-title":"Aav9-mediated vegf-b gene transfer improves systolic function in progressive left ventricular hypertrophy","volume":"20","author":"Huusko","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib24","doi-asserted-by":"crossref","first-page":"H884","DOI":"10.1152\/ajpheart.00796.2006","article-title":"Hemodynamics in the mouse aortic arch as assessed by mri, ultrasound, and numerical modeling","volume":"292","author":"Feintuch","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.RES.0000181759.63239.21","article-title":"P47phox-dependent nadph oxidase regulates flow-induced vascular remodeling","volume":"97","author":"Castier","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.99.2.276","article-title":"Atherosclerosis in apoe*3-leiden transgenic mice: from proliferative to atheromatous stage","volume":"99","author":"Lutgens","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib27","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.tps2621","article-title":"Safety, pharmacokinetics, and antitumor activity of medi3617, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors","volume":"30","author":"Natale","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/15271","article-title":"Requirement for cd154 in the progression of atherosclerosis","volume":"5","author":"Lutgens","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2012.02586.x","article-title":"Using mendelian randomization to determine causative factors in cardiovascular disease","volume":"273","author":"Johansen","year":"2013","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib30","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"Jorgensen","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrcardio.2013.140","article-title":"Demystifying the management of hypertriglyceridaemia","volume":"10","author":"Watts","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib32","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0021-9258(19)85958-6","article-title":"Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins","volume":"255","author":"Goldstein","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1194\/jlr.M700505-JLR200","article-title":"Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized ffas that induce endothelial cell inflammation","volume":"50","author":"Wang","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib34","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Triglyceride Coronary Disease Genetics C","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib35","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2011-03-343293","article-title":"Angiopoietin-2 promotes myeloid cell infiltration in a beta(2)-integrin-dependent manner","volume":"118","author":"Scholz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib36","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1038\/ncomms6962","article-title":"Endothelial destabilization by angiopoietin-2 via integrin beta1 activation","volume":"6","author":"Hakanpaa","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib37","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/ajt.12672","article-title":"Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts","volume":"14","author":"Syrjala","year":"2014","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib38","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/01.CIR.0000054623.35669.3F","article-title":"Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis","volume":"107","author":"Nykanen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system","volume":"10","author":"Augustin","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib40","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1158\/1078-0432.CCR-13-0081","article-title":"Ang-2-vegf-a crossmab, a novel bispecific human igg1 antibody blocking vegf-a and ang-2 functions simultaneously, mediates potent antitumor, antiangiogenic, and antimetastatic efficacy","volume":"19","author":"Kienast","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2362.2003.01173.x","article-title":"Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay","volume":"33","author":"Chung","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2008.11.030","article-title":"Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation","volume":"53","author":"David","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib43","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/HJH.0b013e32832be575","article-title":"Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan\/pravastatin","volume":"27","author":"David","year":"2009","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ijcard.2012.03.120","article-title":"Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men","volume":"167","author":"Golledge","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib45","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.CIR.0000138112.90641.7F","article-title":"Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes","volume":"110","author":"Lee","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/07853890701779586","article-title":"Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension","volume":"40","author":"Patel","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/1354750X.2012.727028","article-title":"Changes and significance of serum angiopoietin-2 levels in patients with coronary heart disease","volume":"17","author":"Wang","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.ATV.0000116864.86607.35","article-title":"Angiopoietin 2 induces cell cycle arrest in endothelial cells: a possible mechanism involved in advanced plaque neovascularization","volume":"24","author":"Calvi","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00019501-200505000-00009","article-title":"Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque","volume":"16","author":"Chen","year":"2005","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.atherosclerosis.2015.05.018_bib50","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1253\/circj.CJ-11-0768","article-title":"Neovascularization and angiogenic factors in advanced human carotid artery stenosis","volume":"76","author":"Pelisek","year":"2012","journal-title":"Circ. J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015013325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015013325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T13:27:28Z","timestamp":1652275648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015013325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0021915015013325"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.05.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}